Genetic Determinants of Coxsackievirus B3 Pathogenesis
✍ Scribed by BRUCE M. McMANUS; BOBBY YANAGAWA; NANA REZAI; HONGLIN LUO; LYDIA TAYLOR; MARY ZHANG; JANE YUAN; JONATHAN BUCKLEY; TIMOTHY TRICHE; GEORGE SCHREINER; DECHENG YANG
- Book ID
- 111397889
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 84 KB
- Volume
- 975
- Category
- Article
- ISSN
- 0890-6564
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Strain‐specific differences in the interaction of coxsackievirus B3 (CVB3) with the coxsackievirus‐adenovirus receptor (CAR) and the decay‐accelerating factor (DAF) co‐receptor proteins were investigated using a non‐haemagglutinating (CVB3) and a haemagglutinating (CVB3‐HA) strain of CV
## Abstract The reasons for the different outcome of coxsackievirus B3 (CVB3)‐induced heart disease in humans are not well understood. Since there are no experimental data on the course of disease after infection with genetically different CVB3 in a natural variable population until now, we studied
## Abstract To understand better how different genomic regions may confer pathogenicity for the coxsackievirus B (CVB), two intratypic CVB1 variants, and a number of recombinant viruses were studied. Sequencing analysis showed 23 nucleotide changes between the parental non‐pathogenic CVB1N and the